Connect with us

News

Turkish Healthcare Startup RS Research Uses Nanotech To Selectively Destroy Tumors

The startup designed a nanotechnology platform for highly targeted delivery of drugs directly to cancer cells.

Published

on

turkish healthcare startup rs research uses nanotech to selectively destroy tumors
Unsplash

All currently available types of treatment for cancer leave a lot to be desired — both in terms of their effectiveness and side effects. Chemotherapy, for example, is effective at preventing cancer from spreading to other parts of the body and even capable of eliminating it entirely, but it can’t tell the difference between cancer cells and healthy cells. Turkish healthcare startup RS Research strongly believes that it has the recipe for significantly increasing the effectiveness of drug-based cancer treatments like chemotherapy.

The startup designed a nanotechnology platform for highly targeted delivery of drugs directly to cancer cells. The platform is called Sagitta, and the name comes from the Latin word for “arrow.”

“Sagitta platform is a groundbreaking technology approach utilizing Polymer Drug Conjugates to target the tumor with a high payload of cytotoxins; resulting in high efficacy with reduced side-effect profile. In addition to moving our own candidates through clinical development, Sagitta platform is available for co-development projects,” explains RS Research on its website.

In other words, Sagitta allows drugs to do their job with minimal side effects, making it possible to avoid causing damage to healthy cells. If everything goes right, the technology could be used to support cancer treatment in Turkey and beyond as early as 2024.

Also Read: FDA Approves Israeli Cancer-Freezing Technology

Together with other innovative cancer treatments, such as gene therapy, hormone replacement therapy, and immunotherapy, scientists and doctors are gradually expanding the range of treatment options available to cancer patients, and we can only hope that a real cure isn’t too far away.

Not too long ago, the FDA approved an Israeli medical technology after demonstrating its ability to eliminate tumors using new cancer-freezing technology.

The COVID-19 pandemic has greatly accelerated many areas of medical research, and it would be a welcome turn of events if some coronavirus-related findings helped finally defeat cancer.

Advertisement

📢 Get Exclusive Monthly Articles, Updates & Tech Tips Right In Your Inbox!

JOIN 17K+ SUBSCRIBERS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Adobe Reveals New AI Tools That Will Wow Photoshop Novices

The company is forging ahead with its Firefly-based AI features, but some professionals have copyright concerns.

Published

on

adobe reveals new ai tools that will wow photoshop novices
Adobe

On Tuesday, April 23, Adobe announced a beta version of Photoshop boasting several fresh features aimed at helping users generate new images and manipulate existing files through text prompts. The latest generative AI additions harness the power of Adobe’s new Firefly Image 3 model.

Among the highlights of the update is the Generate Image tool, designed to generate images based on textual cues, providing users who struggle with a blank canvas a starting point to work from. Additionally, Generative Fill, an existing tool for background completion or image expansion, now incorporates a Reference Image function. The enhancement enables users to guide the tool’s output towards a specific aesthetic or theme by uploading an image as a reference.

adobe photoshop ai update firefly image 3 model

The new AI tools significantly simplify the process of translating creative ideas into images and should be useful to both Photoshop novices and seasoned pros. Firefly Image 3 now has the ability to produce astonishingly realistic images, and its enhanced understanding of text prompts is now considered industry-leading.

Despite facing scrutiny over its training data and a backlash from certain segments of the creative community, Adobe remains committed to integrating generative AI features into its entire software suite. The company continues to assert that Firefly is a safe, ethical option for commercial use and positions it as an alternative to competitors like Midjourney and Stable Diffusion —both of which have faced allegations of using copyrighted material without proper attribution or compensation.

Also Read: Lebanese Newspaper Builds AI President To Beat Political Crisis

Despite Adobe’s confidence in Firefly’s abilities, recent findings have uncovered that its training dataset includes AI-generated images sourced from Midjourney and similar platforms, raising questions about the integrity of Adobe’s claims regarding the model’s commercial viability.

While Adobe maintains that its generative AI models are trained on licensed or public domain content from Adobe Stock, enthusiast Nick St. Pierre recently pointed out on X (formerly Twitter) that “over 13% of all images on Adobe Stock are AI-generated,” and that “most of the generated content comes from Dalle and Midjourney”.

Continue Reading

#Trending